G
GTBiopharma
0 followers
GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia, non-Hodgkin's lymphoma, acute myeloid leukemia, and multiple solid tumors by leveraging their proprietary NK cell engager (TriKE™) platform technology.
Org chart
Michael Breen
Executive Chairman & Interim CEO
Michael Breen
Collapse
Manu Ohri
CFO
Gavin Choy
Chief Clinical Development Officer
Jeffrey S. Miller
Consulting CSO
Stacy Herb
SVP, Portfolio Management
Alan L. Urban
Chief Financial Officer
Board & advisors
Arjun V Balar
Scientific Advisor
Lisa A. Haile
Scientific Advisor
Samir Taneja
Scientific Advisor
Philip Werthman
Scientific Advisor